A Randomized, Double-Blind 4-Week Study to Evaluate the Impact of AXS-05 on Smoking Behavior
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Bupropion/dextromethorphan (Primary) ; Bupropion
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 07 Mar 2018 According to an Axsome Therapeutics media release, initiation of this trial is anticipated in the first half of 2018.
- 23 Feb 2018 Status changed from planning to not yet recruiting.
- 21 Dec 2017 According to a Axsome Therapeutics media release, James M. Davis is the principal investigator for this trial.